Intravenous or subcutaenous rituximab for FL in the SABRINA study
4 Dec 2016
Intravenous or subcutaenous rituximab for FL in the SABRINA study
Updates from the EURO-SKI trial of tyrosine kinase cessation
International Aspirin Foundation Senior Science Award winner
Editor's Choice for November 2016
Research engagement among black men with prostate cancer
Gold nanoparticles and cancer treatment
BMI trajectories: Obesity related cancer risk
Palliative and end of life care
Sentinel node biopsy: Dyes for identification
Managing breast cancer in low and middle income countries
Non surgical treatment of rectal cancer
Involving young people in cancer research